As rats showed enlargement and hypertrophy of liver cells when fed on diet with Furylfuramide in high and low concentrations for a short period of time (Miyaji 1971) , it was expected that hypertrophy of the liver cell might lead to neoplastic changes of the liver. Therefore, a long-term feeding for as long as two years was carried out as described already, and possible co-carcinogenic or accelerative effect was tested by simultaneous and alternate feeding with 4-dimethylaminoazobenzene (Miyaji 1948 ).
MATERIALS AND METHODS

1) Simultaneous feeding of Furylfuramide and 4-dimeethylaminoazobenzene
One hundred two 4-month-old hybrid male rats weighing 135 to 155 g were divided into three groups; 41 rats were given 0.045% DAB alone (Group 1), 20 rats 0.2% Furyl furamide alone (Group 2) and 41 rats 0.045% DAB and 0.2% Furylfuramide simul taneously (Group 3).
A semisynthetic diet consisting of 73% starch, 12% casein, 10% vegetable oil, 4% salt mixture and 1% vitamin mixture was used as the basal diet. As the amount of ribo flavin was important in azo-dye carcinogenesis, it was added at a concentration of 0.2% to the vitamin mixture together with choline chloride at 0.3%. 
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histological examinations. In the meantime, 3 rats each out of Groups 1 and 3 were sacrificed every week from the first to the 7th week , and the liver was subjected to protein-bound azo-dye determination and histological study.
2) Repeated experiment of simultaneous feeding of Furylfuramide and DAB Using the same basal diet, 40 4-month-old male rats weighing 100 to 125g were divided into two groups; one group was fed with DAB alone and the other fed with DAB plus Furylfuramide in the concentration as described above for twenty-four weeks.
3) Experiment on the effect of Furylfuramide feeding on earcinogenesis due to preceding DAB administration 
RESULTS
1) Simultaneous feeding of Furylfuramide and DAB
Though approximately the same amount of DAB was administered to rats in Groups 1 (DAB) and 3 (DAB and Furylfuramide), the amount of protein-bound azo-dye in the liver of Group 3 was lower compared with that of Group 1 which showed two peaks as shown in Fig. 1 . The protein-bound dye in Group 1 showed a plateau in the second week and began to rise in the 4th week , reaching its highest peak in the 6th week and then gradually falling thereafter . In Group 3 the value was lower than that of Group 1. It reached its peak in the 2nd week and decreased gradually with time.
Changes of the liver. Histological examination of the liver was carried out every week until the 7th week of the experiment. Group 1 rats showed more pronounced changes compared with other groups including Group 3 during these 7 weeks. The results obtained at the end of 24 weeks are shown in Table 1 . A fairly high incidence of cyst, cholangiofibrosis and hepatoma was observed in Group 1 compared with rats of Group 3. Nodular hyperplasia was observed in 
Results of alternate feeding of Furylfuramide following DAB administration
Body weight. The curves of average body weight of rats, to which DAB was administered for 8, 10 and 12 weeks in the second experiment, showed a sharp increase in body weight when switched to basal diet, but not so when switched to 0.2% Furylfuramide diet with a distinct difference between the corresponding groups.
Intake of DAB. During the experiment, food intake was measured 3 times a week, and DAB was administered in amounts as shown in Tables 3 and 4 to each rat. Almost the identical value was obtained in two experiments depending on the length of time of DAB administration. 
DISCUSSION
Simultaneous feeding of Furylfuramide with DAB to rats suppressed the development of carcinoma in the liver remarkably as shown in Tables 1 and 2 . However, it was not clear whether the suppression was due to enhanced metabolism of DAB in the liver (Pitot and Heidelberger 1963) , or to delay of synthesis of protein to be bound to DAB, or Furylfuramide competed with DAB for special protein such as `slow h2' (Sorof et al. 1963 ). The amount of protein-bound azo dye in the liver has been considered to be the good measure of the relation of the liver with DAB and the process of carcinogenesis in the liver, as the substance does not appear in the liver of the animal which does not develop carcinoma of the liver with DAB, and it does decrease gradually with malignant change of the liver in Terayama and Sasada 1968) . In the present experiment, the protein-bound azo-dye in the rat fed DAB alone reached a plateau in the 2nd week, and then to its highest peak in the 6th week to fall off gradually with time. In the rats simultaneously fed Furylfuramide and DAB, the lower peak was attained in the 2nd week and the concentration fell gradually thereafter.
The suppressive effect of Furylfuramide in simultaneous administration with DAB was confirmed by Miyaki and his associates repeatedly (Miyaki et al . 1968 (Miyaki et al . , 1969 . Studying the metabolic fate of DAB in the rat fed DAB and Furyl furamide, Miyaki and his associates noted a decrease of DAB and its metabolites in the liver and blood, and an increased activity of the liver to metabolize DAB , when DAB and Furylfuramide were administered to the rat for more than 3 to 4 months. 
